GridAI Technologies (GRDX) Cash from Investing Activities (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Cash from Investing Activities came in at -$12945.0 in Q4 2025, down 114.68% on a QoQ basis from $88169.0 in Q1 2024.
GridAI Technologies (GRDX) Cash from Investing Activities (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 9 years of Cash from Investing Activities data on file, last reported at -$12945.0 in Q4 2025.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$12945.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$12945.0 (down 114.68% YoY) and the FY2025 annual result came in at $323482.0, up 266.89% from the prior year.
- Cash from Investing Activities fell to -$12945.0 in Q4 2025, from $88169.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $88169.0 in Q1 2024 to a low of -$10.2 million in Q4 2021.
- A 3-year average of -$2.0 million and a median of -$12945.0 in 2025 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 4925.59% in 2021, down 11466.76% in 2021.
- Tracing GRDX's Cash from Investing Activities over 3 years: stood at -$10.2 million in 2021, then soared by 100.86% to $88169.0 in 2024, then tumbled by 114.68% to -$12945.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$12945.0 (Q4 2025), $88169.0 (Q1 2024), and -$10.2 million (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - | -12,945.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,945.00 |
| Dec 31, 2025 | -12,945.00 |
| Mar 31, 2024 | 88,169.00 |
| Mar 31, 2024 | 88,169.00 |
| Dec 31, 2021 | -10.25 Mn |
| Dec 31, 2021 | -10.25 Mn |
| Sep 30, 2021 | 2,480.00 |
| Sep 30, 2021 | 2,480.00 |
| Jun 30, 2021 | -73,928.00 |
| Jun 30, 2021 | -73,928.00 |
| Dec 31, 2020 | 90,158.00 |
| Dec 31, 2020 | 90,158.00 |
| Jun 30, 2020 | 1,532.00 |
| Jun 30, 2020 | 1,532.00 |
| Mar 31, 2020 | -4,340.00 |
| Mar 31, 2020 | -4,340.00 |
| Dec 31, 2019 | -6,855.00 |
| Dec 31, 2019 | -6,855.00 |
| Sep 30, 2019 | -3,906.00 |
| Sep 30, 2019 | -3,906.00 |